Abstract: This article presents information about omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acid (PUFA) contents in a broad range of commercially important fish species available on Bulgarian fish markets. The aim is to raise consumers' awareness and encourage them to eat fish. Fish species from the Black Sea coast have relatively high proportion of n-3 PUFAs, of which more than 80% is by EPA (eicosapentaenoic acid, C 20:5 n-3) and DHA (docosahexaenoic acid, C 22:6 n-3). Extensive epidemiological studies show that fish consumption is inversely associated with the incidence of cardiovascular diseases (CVD),
Introduction
The optimal fatty acid (FA) composition of a diet is an important factor in disease prevention and health promotion. The FAO/WHO [7] conclude that "Adequate amounts of dietary fat are essential for health. In addition to their contribution to meeting energy needs, intake of dietary fat must be sufficient to meet the requirements for essential fatty acids". It is well known that fish lipids are one of the best sources of omega-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA). Thus, a more frequent consumption of fish is recommended. Fish is traditionally viewed as a key element of a healthy balanced diet. National dietary recommendations, and those relating to the Mediterranean diet, include advice on regular fish consumption. In Bulgaria, this advice is included in Food-based Dietary Guidelines for Adults in Bulgaria [8] . Fish consumption in different countries varies widely with Japan, Sweden, Norway and Denmark (55-85 g daily) having the highest, moderate in Greece, France, Great Britain (30-25 g/day) and low (below 20 g daily) in Romania, Hungary and many others. The negative trend in recent 2-3 decades in Bulgaria is towards a decrease in fish consumption from 12-14 g/day 35 years ago to 8-10 g/day nowadays (the recommendation being at least 30 g/day) [17] . We examined the nutritional and health benefits of commercially important fish in Bulgaria as a valuable source of omega PUFAs and present useful information for consumers about these biologically active components in this article. Physiological function of omega-3 and omega-6 PUFA FAs belong to the class of simple lipids, composed of a hydrocarbon chain with a methyl group and a terminal carboxyl group. They are categorized into three classes: saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA) [24] . There are two main families of PUFA: n-3 and omega-6 (n-6). These FAs are not convertible and have very different biochemical roles in the human body. Linoleic acid (18:2n-6, LA) and alpha-linolenic acid (18:3n-3, ALA) are known as dietary essential FAs (EFA) because they prevent deficiency symptoms and cannot be synthesized by the human body. The family of long chain n-3PUFA comprises eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA), which are all derived from the parent fatty acid -ALA. While the ratios of these FAs vary as per the food source, DPA is typically less prevalent than EPA and DHA. The family of long chain n-6 PUFA comprises Gama-linolenic acid (18:3n-6, GLA) and arachidonic acid (20:4n-6, ARA), which are derived from the parent fatty acid LA [6, 12, 20] . The n-6 PUFA deficiency symptoms are dermatitis, growth retardation and infertility in relation to its biological function: LA is a structural component of the skin ceramides, acting as a water barrier; ARA is a precursor of eicosanoids. N-3 deficiency is responsible for insulin resistance and metabolic syndrome, brain metabolic abnormalities, liver steatosis and non-alcoholic fatty liver disease [23] . Furthermore, deficiency of n-3 PUFA leads to a loss of DHA in the brain and retina-rod outer segment phospholipids with a compensatory replacement by 22:5 n-6. This minor change in the membrane phospholipid structure is sufficient to lead to memory loss, learning disabilities and impaired visual acuity [20] . The n-3 FA can partially substitute the n-6 FAs thus alleviating some of the EFA deficiency symptoms. Some of the proven beneficial biological functions of dietary n-3 PUFAs in the organism are related to the provision of energy and carbon atoms; the capability to reduce the amount of serum lipids, EPA as a precursor for "n-3 eicosanoids" which directly influences the vascular physiology and the vascular system; the specific role of DHA in the membrane function, especially in the retina and the neuronal tissues. The quantitative ratio between both series must be taken into consideration for an appropriate physiological balance [23] . This FA ratio is important because n-3 cannot be converted to an n-6 PUFA in humans, the n-3 content influences the n-6 concentration and vice-versa. Therefore, the human capacity to synthesize the DHA can be inhibited by a high intake of n-6 LA. The balance between n-6 and n-3 PUFA in a diet is essential for the homeostasis, the normal growth and the development, because the eicosanoid metabolic products from n-6 and n-3 FAs exhibit opposing biological properties [6, 20, 23] . Most scientific studies on n-3 PUFAs in recent years aim at determining their immunological and anti-inflammatory effects, especially in cases of asthma, rheumatic arthritis and autoimmune diseases [20, 23, 24] . A lot of studies report on the health benefits of n-3 PUFA intake in relation to cardio vascular disease (CVD) risk factors [12, 14] . Several possible mechanisms by which n-3 PUFAs (as fish lipids) would lead to a reduced CVD risk are established: decrease of triglyceride levels, slowed down metabolism of n-6 PUFA eicosanoids and inhibition of processes of inflammation or related to the increase in HDL cholesterol levels [4] . In a meta-analysis of prospective cohort studies, He et al. [10] estimate that eating fish once a week is associated with a 15% lower risk of coronary death compared to a fish intake of less than once a month. Each 20-g/d increase in fish consumption is related to a 7% lower risk of CHD mortality. The marine-derived LCFA n-3 PUFA EPA and DHA are assumed to be primarily responsible for these health effects. The basic mechanism by which n-3 FA may reduce the risk of CVD is by EPA and DHA levels increase in the phospholipid membranes. Mozaffarian and Rimm [16] combine data from prospective cohort studies to estimate that a reduction of CVD mortality may be achieved with relatively low intakes of EPA and DHA. Modest consumption of fish (1-2 servings/wk, which is 100-200 g fish/wk) is associated with a 36% lower risk of coronary death. Freshwater fish contains lower proportions of n-3 PUFAs and higher amounts of n-6 PUFAs than salt water fish. Therefore, the ratio of total n-3 to n-6 fatty acids is much lower for freshwater fish than for sea fish, usually ranging from 1 to about 5. Several studies report that cold-water fish contains higher amounts of n-3 PUFA. Water temperature seems to be an important abiotic factor influencing such amounts [23, 24] . A comparison between the n-3 and n-6 PUFA content and the n-6/n-3 FA ratio in commercially important Bulgarian fish species and internationally published data for the same species is shown in Table 1 . The information about fish PUFA composition (Table 1) reveals that Black Sea fish species are a very good source of n-3 PUFA (19.40% -23.60% of total FA). Freshwater rainbow trout contains significantly higher n-3 values (19.00%) compared to carp and catfish (4.70-9.83%). Moreover, an unbalanced n-6/n-3 ratio with a prevalence of n-6 PUFAs is highly prothrombotic and proinflammatory, and stimulates the development of atherosclerosis, obesity and diabetes. Due to these facts, a balanced n-6/n-3 ratio 2:1 is one of the most important dietary factors in the prevention of obesity, CVD and other chronic diseases. According to some nutritional recommendations [1, 5, 7] , the n-6/n-3 ratio in human diets should not exceed 5.0. All fish species in the present study had an n-6/n-3 ratio within the recommended range. The FA composition of fish lipids varies significantly, especially when compared to vegetable oils and is regulated by the diet, location, season and physiological conditions such as age and sex of the species, which explains the differences observed between fish species n-3 PUFA values. The provision of ALA, EPA and DHA through fish lipids in Bulgaria was among the lowest in the world, which is consistent with the low ALA and DHA levels established in adipose tissue of patients with CVD. An international epidemiological investigation in 2011 [28] finds that forty-seven countries (including Bulgaria as a participant) have almost no access to n-3 PUFAs. The estimated fish intake in Bulgaria (57 g/week) corresponds to an average intake of less than one portion per month. This amount is consistent with our findings about Bulgaria having the lowest ALA and DHA human adipose tissue levels compared to Finland, Germany, Netherlands, Norway, Spain, and the UK. The average adipose tissue ALA in Bulgaria is comparable to the levels found among those with the highest risk of myocardial infarction in Costa Rica. Not surprisingly, regions with the lowest CVD mortality (North America, Europe and Oceania) have high n-3 availability, whereas in Bulgaria, the country with the smallest reduction in CVD mortality, the n-3PUFA intake is not increased [28] . By combining a lower intake of n-6 PUFAs with a higher intake of n-3 PUFAs e.g. through the consumption of Black Sea or freshwater fish species, a relatively significant effect may be achieved.
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Conclusion
Omega-3 FAs as constituents of fish and seafood are the only food source of the long chain fatty acids (EPA and DHA) for humans. Scientific information on FA composition of traditionally consumed fish in Bulgaria is scarce. This study provides recent information on n-3 and n-6 PUFAs content of fish species, well-known in Bulgaria. Based on the current data we can conclude that Black Sea fish species are a very good source of n-3 PUFA (ranging from 19.40% to 23.60% of total FA). Freshwater rainbow trout shows significantly higher n-3 values (19% of total FA) compared to carp and catfish. All fish species in this study have the optimal n-6/n-3 ratio within the recommended range. A balanced diet where fish is consumed at least twice weekly can supply the daily needs of n-3 PUFA in our country. An increased consumption of fish could lead to a reduction of the occurrence and the degree of severity of chronic diseases. 
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